Sophie Momen

ORCID: 0000-0002-8520-5739
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • DNA Repair Mechanisms
  • Skin Protection and Aging
  • Drug-Induced Adverse Reactions
  • Genomics and Rare Diseases
  • Cancer and Skin Lesions
  • Mast cells and histamine
  • Dermatologic Treatments and Research
  • Sarcoidosis and Beryllium Toxicity Research
  • Lung Cancer Treatments and Mutations
  • Autoimmune and Inflammatory Disorders
  • Acne and Rosacea Treatments and Effects
  • melanin and skin pigmentation
  • Endoplasmic Reticulum Stress and Disease
  • Autoimmune Bullous Skin Diseases
  • Mental Health via Writing
  • Cutaneous Melanoma Detection and Management
  • Peripheral Neuropathies and Disorders
  • Oral Health Pathology and Treatment
  • Hidradenitis Suppurativa and Treatments
  • Child and Adolescent Health
  • Genetic and rare skin diseases.
  • Molecular Biology Techniques and Applications
  • Vascular Tumors and Angiosarcomas

Hutchison/MRC Research Centre
2020-2024

St John's Hospital
2014-2024

Guy's and St Thomas' NHS Foundation Trust
2016-2023

Cancer Institute (WIA)
2023

University of Cambridge
2019-2022

Cancer Research UK Cambridge Center
2022

Guy's Hospital
2022

Office of Multidisciplinary Activities
2021

King's College Hospital
2017-2021

MRC Cancer Unit
2020

Whole-genome sequencing (WGS) permits comprehensive cancer genome analyses, revealing mutational signatures, imprints of DNA damage and repair processes that have arisen in each patient's cancer. We performed signature analyses on 12,222 WGS tumor-normal matched pairs, from patients recruited via the UK National Health Service. contrasted our results to two independent datasets, International Cancer Genome Consortium (ICGC) Hartwig Foundation, involving 18,640 cancers total. Our add 40...

10.1126/science.abl9283 article EN Science 2022-04-21
Xueqing Zou Gene Ching Chiek Koh Arjun S. Nanda Andrea Degasperi Katie Urgo and 95 more Theodoros I. Roumeliotis Chukwuma A. Agu Cherif Badja Sophie Momen Jamie Young Tauanne Dias Amarante Lucy Side Glen Brice Vanesa Pérez‐Alonso Daniel Rueda Céline Gomez Wendy Bushell Rebecca Harris Jyoti S. Choudhary John C. Ambrose Prabhu Arumugam Emma L. Baple Marta Bleda F. Boardman-Pretty Jeanne M. Boissiere C. R. Boustred Helen Brittain Mark J. Caulfield G. C. Chan Clare Craig Louise C. Daugherty Anna de Burca A. Devereau Greg Elgar Rebecca E. Foulger Tom Fowler Pedro Furió‐Tarí Adam Giess Joanne M. Hackett Dina Halai Angela Hamblin Bingyang Shi James E. Holman Tim Hubbard Kristina Ibáñez Robert W. Jackson J. Louise Jones Dalia Kasperavičiūtė Melis Kayikci Athanasios Kousathanas L. Lahnstein Kay Lawson S. E. A. Leigh I. U. S. Leong Javier Ferreiros F. Maleady-Crowe Joanne Mason Ellen M. McDonagh Loukas Moutsianas Michael Mueller Nirupa Murugaesu Anna C. Need Pter O’Donovan Chris A. Odhams Andrea Orioli Christine Patch Mariana Buongermino Pereira D. Perez-Gil Dimitris Polychronopoulos J. Pullinger T. Rahim Augusto Rendon Pablo Riesgo-Ferreiro Tim Rogers Mina Ryten K. Savage Kushmita Sawant Richard H. Scott Afshan Siddiq A. Sieghart Damian Smedley Katherine R. Smith Samuel C. Smith Alona Sosinsky William Spooner Helen E. Stevens Alexander Stuckey Răzvan Sultana M. Tanguy Ellen Thomas Simon R. Thompson Carolyn Tregidgo Arianna Tucci Emma Walsh Sarah A. Watters M. J. Welland Eleanor Williams Katarzyna Witkowska S. M. Wood Magdalena Zarowiecki

10.1038/s43018-021-00200-0 article EN Nature Cancer 2021-04-26

“Mutational signatures” are patterns of mutations that report DNA damage and subsequent repair processes have occurred. Whole-genome sequencing (WGS) can provide additional information to standard diagnostic techniques identify therapeutic targets. A 32-yr-old male with xeroderma pigmentosum developed metastatic angiosarcoma was unresponsive three lines conventional sarcoma therapies. WGS performed on his primary cancer revealing a hypermutated tumor, including clonal ultraviolet...

10.1101/mcs.a004408 article EN Molecular Case Studies 2019-10-01

Xeroderma pigmentosum (XP) is caused by defective nucleotide excision repair of DNA damage. This results in hypersensitivity to ultraviolet light and increased skin cancer risk, as sunlight-induced photoproducts remain unrepaired. However, many XP patients also display early-onset neurodegeneration, which leads premature death. The mechanism neurodegeneration unknown. Here, we investigate using pluripotent stem cells derived from healthy relatives, performing functional multi-omics on...

10.1016/j.celrep.2024.114243 article EN cc-by Cell Reports 2024-05-27

Abstract The mechanisms that underpin how insertions or deletions (indels) become fixed in DNA have primarily been ascribed to replication-related and/or double-strand break (DSB)-related processes. Here, we introduce a method evaluate indels, orientating them relative gene transcription. In so doing, reveal number of surprising findings: First, there is transcriptional strand asymmetry the distribution mononucleotide repeat tracts reference human genome. Second, strong indels across 2,575...

10.1038/s41467-020-15901-w article EN cc-by Nature Communications 2020-04-24

Xeroderma pigmentosum (XP), a rare disease with defects in DNA repair genes, has >1,000-fold increased risk of ultraviolet-induced skin cancers. Immune checkpoint inhibitors (ICIs) are used for treating cancers large numbers mutations but may also promote adverse events (AEs). Deficient XP patients lead to mutations, leading enhanced efficacy cancer response or, alternatively, AE ICI. We sought compare the and ICI metastatic or unresectable that ICI-treated general population.In this...

10.3389/fonc.2023.1282823 article EN cc-by Frontiers in Oncology 2023-10-25

Abstract Photodermatoses comprise a heterogeneous group of disorders characterized by abnormal skin responses following physiological exposure to solar radiation. Previous investigations have established that photodermatoses are associated with significant psychological morbidity and poor health-related quality life (HRQoL), although few studies quantified this phenomenon in large patient cohorts. Therefore, the aim study was perform cross-sectional evaluation patient-reported HRQoL tertiary...

10.1093/bjd/ljae090.167 article EN other-oa British Journal of Dermatology 2024-06-28

We present a 21-year-old HIV-negative Somalian male who was diagnosed with an immunohistochemically proven human herpes virus 8 (HHV8)-positive primary penile Karposi’s Sarcoma (KS). He treated local surgery and remained in complete clinical remission for 18 months. This is the first case of heterosexual teenage young adult (TYA) patient KS without history sexual intercourse. provides evidence that may be transmitted through routes other than transmission.

10.17925/eoh.2014.10.2.2 article EN European Oncology & Haematology 2014-01-01
Coming Soon ...